Pathway to Cures

📍 New York, United States🗓 Founded 2022👥 4 employees
Venture Capital and Private Equity Principals🌐 pathwaytocures.org
Website LinkedIn
Pathway to Cures (P2C) is a venture philanthropy fund created specifically to accelerate the development of cures across all inheritable blood disorders. As a flexible partner working collaboratively with other organizations, P2C makes investments in innovative therapies and technologies, leveraging the deep resources and scientific community relationships of the National Hemophilia Foundation (NHF). By reinvesting proceeds from investments back into the Fund, P2C will amplify our impact by supporting the progress of promising companies and building a deep and diverse portfolio of investments that further our mission.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Pathway to Cures founded?
Pathway to Cures was founded in 2022.
What industry is Pathway to Cures in?
Pathway to Cures operates in Venture Capital and Private Equity Principals. Find similar Venture Capital and Private Equity Principals investors on gritt.io.
Where is Pathway to Cures based?
Pathway to Cures is headquartered in New York, United States.